Navigation Links
Shining the soothing light
Date:10/21/2013

Almost all patients suffering from head and neck squamous cell carcinoma (HNSCC) develop canker sores, a complication resulting from different modalities of treatment, namely stem cell transplantation, chemotherapy, and radiotherapy. Canker sore is divided in five grades (zero to four) by the World Health Organization (WHO), with severe cases (grades 3 and 4) being associated with pain, weight loss, poor quality of life, and higher hospital costs due to increased healthcare needs. Severe canker sore can also lead to treatment interruption, which may decrease the patient's chances of surviving the cancer.

No effective preventative strategy is currently available for canker sore, but prospective trials of low-level laser therapy (LLLT) done in HNSCC patients undergoing chemoradiotherapy showed promising results. However, additional trials detected a high incidence of canker sore among patients, leaving the question of whether LLLT can effectively prevent canker sore still open.

Now, a group of scientists led by Dr. Heliton Spindola Antunes at the National Cancer Institute (INCA) in Rio de Janeiro, Brazil, has successfully performed a definitive trial showing that LLLT reduces the occurrence of canker sore in HNSCC patients undergoing concurrent chemoradiotherapy and improves patient's quality of life.

The trial was performed with 94 HNSCC patients undergoing chemoradiotherapy. They were divided into two groups of 47 individuals, one of which received LLLT while the other received placebo. Researchers observed a significant difference in the incidence of canker sore grades 3 and 4 between groups. For instance, while in the group of patients receiving LLLT only three patients developed severe cases of canker sore, in the group receiving the placebo this number was 19. There were also significant differences in the absence of canker sore (grades 0-1), with the LLLT group having 59.6% of patients free of canker sore as opposed to 21.3% in the placebo group. The LLLT group had less severe oral pain and, as a result, used fewer opioid analgesics. They were also less likely to require gastrostomy (a surgical opening into the stomach for nutritional support) throughout the cancer treatment.

"For ethical reasons," says Dr Antunes, "all patients who developed canker sore grades 3 or 4 in the placebo arm were then offered the option of receiving LLLT. They all improved to grade 2 or lower, supporting the evidence that LLLT is an effective choice to prevent or treat canker sore in these patients."


'/>"/>

Contact: Heliton Spindola Antunes
hspindola@inca.gov.br
55-213-207-6597
Publicase Comunicao Cientfica
Source:Eurekalert

Related medicine news :

1. Mother-Baby Sleep Experts Offer Tips for Soothing Crying Babies, Giving Exhausted Mothers Alternatives to Crying It Out
2. Soothing sounds during cataract surgery reduces patient anxiety
3. Cataract Patients Relax to a Soothing Beat, Study Says
4. Nationwide Title Clearing, Inc. Prepares for “Light the Night Walk” for Cancer Fundraising
5. Into Action Treatment Sponsors NOPE Annual Candlelight Vigil
6. Specialized Lighting Products Designed by Daylight Now Offered by Rehabmart.com
7. Deepak Chopra Introduces Dream Weaver App for Smartphones with Strobe Lights, Making It Easy to Experience the Benefits of Meditation & Deep Relaxation Automatically
8. Mesothelioma Awareness Day Sheds Light on Deadly Cancer
9. Joseph Gordon-Levitt’s “Don Jon” Spotlights the Health Problems with Porn
10. Go Healthy Next Announces the SaunaFix, a Portable Sauna Featuring Near Infrared Light Therapy
11. FHFA Highlights Homeowners HARP Refinancing: Eligibility Is Easier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Earlier this month, the Workgroup ... of health IT to create efficiencies in healthcare information exchange and a trusted advisor ... Summer Forum which featured keynote addresses by Donald W. Rucker, MD, head of ...
(Date:8/23/2017)... , ... August 23, 2017 , ... Nightingale College continues ... Give Back Day is a time Nightingale College dedicates to serving and volunteering for ... thrive on donations and volunteers or those that need a little extra help. ...
(Date:8/23/2017)... ... 23, 2017 , ... Boling Vision Center is excited to ... is now seeing patients at Boling Vision Center’s Elkhart & Notre Dame locations. ... treatment of eye disease, medical retina, high-technology cataract surgery, cosmetic procedures, and ...
(Date:8/23/2017)... Silver Spring, MD (PRWEB) , ... August 23, ... ... in two categories of the Golden Bridge Awards® - for Risk Management Solution ... new Secure Halo™ online platform released in 2017 and its DHS ...
(Date:8/22/2017)... ... , ... The Women’s Choice Award, a growing platform that gives a voice ... Choice Award. The identification by women of an effective new migraine relief product ... women. In a survey taken by the Women’s Choice Award organization, nine out of ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 AccuGenomics, Inc., ... , today announced that the company has provided ... University of North Carolina at Chapel Hill and to ... designed to characterize and quantify HIV reservoir and viral ... pharmacological intervention. The HIV Cure Center is a joint ...
(Date:8/14/2017)... PETACH TIKVAH, Israel , Aug. 15, ... leading developer of adult stem cell technologies for neurodegenerative ... June 30, 2017. ... our pivotal Phase 3 trial to investigate NurOwn ® ... and Chief Executive Officer of BrainStorm. "We have agreements ...
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
Breaking Medicine Technology: